Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2001
04/26/2001WO2001029038A1 Tricyclic fused-imidazole derivatives
04/26/2001WO2001029037A2 Condensed naphthyridines as hiv reverse transcriptase inhibitors
04/26/2001WO2001029036A2 Allosteric sites on muscarinic receptors
04/26/2001WO2001029027A1 2-alkoxybenzene derivatives
04/26/2001WO2001029000A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
04/26/2001WO2001028993A2 Tyrosine kinase inhibitors
04/26/2001WO2001009129A3 1h-pirido[3, 4-b]indol-1-one derivatives
04/26/2001WO2000008020A8 Tricyclic carboxamides
04/26/2001US20010000521 Biological activity inhibiting topoisomerase I and/or topoisomerase II; antitumor agents, viricides
04/26/2001DE19951022A1 New pyridoindolylmethyl-phenylacetic acid amide derivatives useful in lowering serum cholesterol levels in treatment of e.g. atherosclerosis, coronary heart disease, apoplexy and thromboses
04/26/2001DE19860972A1 Verfahren zur Herstellung derivatisierter Polymere A process for preparing derivatized polymers
04/26/2001CA2387896A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors
04/26/2001CA2387840A1 Tyrosine kinase inhibitors
04/26/2001CA2386942A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/26/2001CA2386149A1 Allosteric sites on muscarinic receptors
04/26/2001CA2386049A1 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
04/25/2001EP1094066A2 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
04/25/2001EP1094064A1 5-arylindolederivatives and their use as serotonin(5-ht1)agonists
04/25/2001EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
04/25/2001CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/25/2001CN1292698A Glycine transport inhibitors
04/25/2001CN1292697A Anti-viral compound
04/25/2001CN1292264A Phosphodiesterase inhibitor and its use
04/24/2001US6222047 Pyrocarbonic acid diesters and the preparation and use thereof
04/24/2001US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221875 Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands
04/24/2001US6221872 Debrominating a pyrrole; fusing the product with an amidine; condensing the product with a nucleophile; reducing and purifying
04/24/2001US6221150 For dispersing pigments; rheology
04/24/2001CA2220055C Dipeptides which promote release of growth hormone
04/19/2001WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
04/19/2001WO2001027118A2 Bicyclic imidazo-5-yl-amine derivatives
04/19/2001WO2001027116A2 Condensed dihydroquinolinone derivatives for inhibiting mrp1
04/19/2001WO2001027111A2 Bicyclic imidazo-3-yl-amine derivatives
04/19/2001WO2001027110A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
04/19/2001WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/19/2001WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method
04/19/2001WO2001027103A1 Fab i inhibitors
04/19/2001WO2001027087A2 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
04/19/2001WO2001027084A1 Beta disubstituted metalloprotease inhibitors
04/19/2001WO2001026653A1 V TYPE AND/OR X TYPE sPLA2 INHIBITORS
04/19/2001WO2000073274A3 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
04/19/2001DE19948417A1 Imidazol-Derivate und ihre Verwendung als Arzneimittel Imidazole derivatives and their use as medicaments
04/19/2001CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method
04/19/2001CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/19/2001CA2386485A1 Beta disubstituted metalloprotease inhibitors
04/18/2001EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them
04/18/2001EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same
04/18/2001EP1091961A1 Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
04/18/2001EP1091959A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
04/18/2001EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
04/18/2001EP0968250B1 Soluble chromophores having improved solubilising groups
04/18/2001EP0843678B1 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives
04/18/2001EP0723544B1 ALKOXY ALKYL CARBAMATES OF IMIDAZO[1,2-a]PYRIDINES
04/18/2001CN1291984A Glycine transport inhibitors
04/18/2001CN1291975A Process for preparing protected 4-aminomethyl-pyrrolidin-3-one
04/18/2001CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors
04/17/2001US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies
04/17/2001US6218413 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
04/17/2001US6218404 Therapy and prophylaxis of neuronal loss associated with stroke, ischemia, cns trauma, hypoglycemia and surgery, neuro-degenerative diseases including alzheimer's disease, amyotrophic lateral sclerosis, huntington's disease
04/17/2001US6218402 Antagonizing the serotonin 5ht3 receptor with a pyrrolo quinoline derivative
04/17/2001US6218400 Treating angina, hypertension, pulmonary disease, vascular disorders, stroke, bronchitis, asthma, rhinitis, glaucoma, sexual disorders, and disorders of gut motility
04/17/2001US6218399 Modifying the 20 position of camptothecin to form a compound which is low toxicity used in cancer therapy
04/17/2001US6218392 For therapy and prophylaxis of ischemic heart diseases such as angina pectoris, myocardial infarct and chronic and acute cardiac failure, pulmonary hypertension, arteriosclerosis and bronchial asthma
04/17/2001US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives
04/17/2001US6218384 3-Oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
04/17/2001US6218381 Fused imidazole derivatives as multidrug resistance modulators
04/17/2001US6218379 As antibacterial
04/17/2001US6218359 Treating autoimmune, arthritic, tumor diseases
04/17/2001CA2158457C Naphthalene derivatives
04/17/2001CA2110670C Spiro piperidines and homologs which promote release of growth hormone
04/17/2001CA2080475C Neuroprotective indolone and related derivatives
04/17/2001CA2027765C Mevinic acid derivatives
04/17/2001CA2010963C Process for the preparation of lactam derivatives
04/15/2001CA2301491A1 Novel 7-aminopyrido [2,3-d]pyrimidine derivatives
04/12/2001WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
04/12/2001WO2001025237A1 Novel imidazopyridine carbonitrile compounds
04/12/2001WO2001025220A1 Triazine kinase inhibitors
04/12/2001WO2001025213A2 Pyrrolo imidazole derivatives and their use as medicaments
04/12/2001WO2001025200A1 Cyclic amine compounds as ccr5 antagonists
04/12/2001WO2001024797A1 Integrin receptor antagonists
04/12/2001WO2000076996A3 Method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane
04/12/2001WO2000056304A3 Anti-inflammatory uses of manzamines
04/12/2001WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2
04/12/2001WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
04/12/2001CA2608807A1 Cyclic amine compounds as ccr5 antagonists
04/12/2001CA2386795A1 Pyrrolo imidazole derivatives and their use as medicaments
04/12/2001CA2386218A1 Triazine kinase inhibitors
04/12/2001CA2386030A1 Integrin receptor antagonists
04/12/2001CA2385251A1 Novel imidazopyridine carbonitrile compounds
04/11/2001EP1090009A2 Cell adhesion-inhibiting antinflammatory compounds
04/11/2001EP1090008A1 Syntheses of a variety of lamellarin compounds and analogues
04/11/2001EP1089993A1 5-ht 1f? agonists
04/11/2001EP1089988A1 Fluorophenyl resin compounds
04/11/2001EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis.
04/11/2001EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
04/11/2001EP0662076B1 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity
04/11/2001CN1064360C Fused imidazo [1,2-alpha] pyridines
04/11/2001CN1064357C Novel antimicrobial 5-(N-heterosubstiluted amino) quinolones and medicinal composition
04/11/2001CN1064354C Trilcyclic benzazepine vasopressin antagnonists